Latest Inflammatory bowel disease Stories
PARIS, November 12, 2014 /PRNewswire/ -- Collaboration to generate novel diagnostic products to support personalized therapies for
MILPITAS, Calif., Nov.
PINEHURST, N.C., Oct.
LA JOLLA, Calif., and JUPITER, Fla., Oct.
"Get Your Full Course" addresses diet and nutritional considerations related to inflammatory bowel diseases and highlights Sunny's personal story of living with ulcerative colitis HORSHAM,
Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Oct.
AG014 Safe and Well Tolerated, Successful Localized GI Delivery of Drug With No Systemic Exposure GHENT, Belgium, Oct.
-- HUMIRA is now indicated to treat pediatric patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators
- A hairdresser.